FDA’s first clearance of AI for autonomous detection of diabetic retinopathy
A system designed by a University of Iowa ophthalmologist that uses artificial intelligence (AI) to detect diabetic retinopathy without a person interpreting the results earned Food and Drug Administration (FDA) authorization in April, following a clinical trial in primary care offices.
Results of that study were published Aug. 28 online in Nature Digital Medicine, offering the first look at data that led to FDA clearance for IDx-DR, the first medical device that uses AI for the autonomous detection of diabetic retinopathy.
The clinical trial, which also was the first study to prospectively assess the safety of an autonomous AI system in patient care, compared the performance of IDx-DR to the gold standard diagnostic for diabetic retinopathy, which is the leading cause of vision loss in adults and one of the most severe complications for the 30.3 million Americans living with diabetes.
IDx-DR exceeded all pre-specified superiority endpoints in sensitivity, the ability to correctly identify a patient with disease; specificity, the ability to correctly classify a person as disease-free; and imageability, or the capability to produce quality images of the retina and determine the severity of the disease.
“The AI system’s primary role is to identify those people with diabetes who are likely to have diabetic retinopathy that requires further evaluation by an eye-care provider. The study results demonstrate the safety of autonomous AI systems to bring specialty-level diagnostics to a primary care setting, with the potential to increase access and lower cost,” says Michael Abràmoff, MD, PhD, the Robert C. Watzke Professor of Ophthalmology and Visual Sciences with UI Health Care and principal investigator on the study. He is founder and president of IDx, the company that created the IDx-DR system and funded the study.
Early detection may prevent vision loss
More than 24,000 people in the United States lose their sight to diabetic retinopathy each year. Early detection and treatment can reduce the risk of blindness by 95 percent, but less than 50 percent of patients with diabetes schedule regular exams with an eye-care specialist.
In the study, 900 adult patients with diabetes—but no history of diabetic retinopathy—were examined at 10 primary care sites across the country. Retinal images of the patients were obtained using a robotic camera, with an AI assisting the operator in getting good quality images.
Once the four images were complete, the diagnostic AI then made a clinical diagnosis in 20 seconds. The diagnostic AI detects disease just as expert clinicians do, by having detectors for the lesions characteristic for diabetic retinopathy, including microaneurysms, hemorrhages, and lipoprotein exudates.
Camera operators in the study were existing staff of the primary care clinics, and not physicians or trained photographers.
“This was much more than just a study testing an algorithm on an image. We wanted to test it in the places where it will be used, by the people who will use it, and we compared it to the highest standard in the world,” says Abràmoff, who also holds faculty appointments in the UI College of Engineering.
AI measured against gold standard
Study participants also had retinal images taken at each of the primary care clinics using specialized widefield and 3D imaging equipment without AI and operated by experienced retinal photographers certified by the Wisconsin Fundus Photograph Reading Center (FPRC)—the gold standard in grading the severity of diabetic retinopathy.
Complete diagnostic data accomplished by both the AI system and FPRC readers was available for 819 of the original 900 study participants. FPRC readers identified 198 participants with more than mild diabetic retinopathy who should be further examined by a specialist; the AI was able to correctly identify 173 of the 198 participants with disease, resulting in a sensitivity of 87 percent. Among the 621 disease-free participants identified by FPRC readers, AI identified 556 participants, for a specificity of 90 percent. The AI had a 96 percent imageability rate: of the 852 participants who had an FPRC diagnosis, 819 had an AI system diagnostic output.
Learn more: Study shows AI can deliver specialty-level diagnosis in primary care setting
The Latest on: IDx-DR
[google_news title=”” keyword=”IDx-DR” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: IDx-DR
- Sapient Appoints Jonathan Usuka as Chief Business Officeron May 7, 2024 at 6:06 am
Sapient, a leading biomarker discovery organization providing at scale services for multi-omics data generation and analysis, has announced the appointment of Jonathan Usuka, PhD, MBA as Chief ...
- IDX SRI-KEHATI (JKSRI)on May 6, 2024 at 2:00 am
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
- Nippon India Nifty SDL Plus G-Sec - Jun 2028 Mat 70:30 Idx Fd Dr Payout Inc Dist cum Cap Wdrlon May 2, 2024 at 5:00 pm
What is the category of Nippon India Nifty SDL Plus G-Sec - Jun 2028 Mat 70:30 Idx Fd Dr Payout Inc Dist cum Cap Wdrl ? The category of Nippon India Nifty SDL Plus G-Sec - Jun 2028 Mat 70:30 Idx ...
- IDX Composite climbs up by 1.7%, retouches 7,100 markon April 28, 2024 at 5:00 pm
he Indonesia Stock Exchange (IDX) Composite (IHSG) closed significantly higher on Monday amid a wait-and-see approach adopted by investors ahead of key global economic data releases this week.
- Dr. Alphonsus Obayuwanaon April 25, 2024 at 1:19 pm
Dr. Alphonsus Obayuwana, MD, PhD, CPC, is a physician-scientist, happiness coach, and the founder and CEO of Triple-H Project LLC, dedicated to the promotion of more hopeful and happier communities.
- Nippon India Nifty SDL Plus G-Sec - Jun 2028 Mat 70:30 Idx Fd Dr Growthon April 22, 2024 at 4:59 pm
What is the category of Nippon India Nifty SDL Plus G-Sec - Jun 2028 Mat 70:30 Idx Fd Dr Growth ? The category of Nippon India Nifty SDL Plus G-Sec - Jun 2028 Mat 70:30 Idx Fd Dr Growth is Fixed ...
- IDX Composite ends Tuesday trading up 0.52 percenton April 22, 2024 at 4:59 pm
he Indonesia Stock Exchange (IDX) Composite closed up 36.99 points, or 0.52 percent, on Tuesday, ending the day’s trading session at 7,110.81. A total of 270 stocks rose, 288 stocks fell and 225 ...
- Dr. Phil's jaw drops when guest uses colonialism as justification for squatters: 'Take that land back'on April 19, 2024 at 3:30 am
Dr. Phil spoke with property owners about how squatters are using legal loopholes to occupy properties, but one real estate agent argued that it can be justified because of a history of ...
- Dr Pepper is bringing a new, limited-time coconut flavor to a store near you: What to knowon April 17, 2024 at 9:29 am
Dr Pepper has a new flavor coming out just in time for summer. The company announced Dr Pepper Creamy Coconut and Dr Pepper Creamy Coconut Zero Sugar will be available beginning May 1 at retailers ...
- IDX Identity Theft Protection Review | Moneyon April 16, 2024 at 1:00 pm
Founded in 2003, IDX provides cybersecurity services to individuals and businesses — including many high-profile clients, such as Nike, Uber and several federal agencies. In this comprehensive ...
via Bing News